Viewing Study NCT03426995


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-03 @ 2:25 AM
Study NCT ID: NCT03426995
Status: TERMINATED
Last Update Posted: 2020-12-02
First Post: 2018-02-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-03-13
Start Date Type: ACTUAL
Primary Completion Date: 2019-05-02
Primary Completion Date Type: ACTUAL
Completion Date: 2019-05-02
Completion Date Type: ACTUAL
First Submit Date: 2018-02-02
First Submit QC Date: None
Study First Post Date: 2018-02-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-11-06
Results First Submit QC Date: None
Results First Post Date: 2020-12-02
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-06
Last Update Post Date: 2020-12-02
Last Update Post Date Type: ACTUAL